| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2022 | Dec 16, 2022 | Farfel Gail M CEO | Buy | Promis Neurosciences Inc. | PMN | $4.94 | $4,940 | +33.33% |
| Dec 06, 2022 | Dec 08, 2022 | Farfel Gail M CEO | Buy | Promis Neurosciences Inc. | PMN | $5.7 | $5,700 | +50.00% |
| May 16, 2022 | May 19, 2022 | Farfel Gail M Dir | Buy | Durect Corp | DRRX | $0.4 | $22,012 | +35.57% |
| May 11, 2022 | May 14, 2022 | Farfel Gail M Dir | Buy | Durect Corp | DRRX | $0.4 | $8,258 | +31.61% |
| May 10, 2022 | May 13, 2022 | Farfel Gail M Dir | Buy | Durect Corp | DRRX | $0.41 | $950 | +8.85% |
| May 09, 2022 | May 11, 2022 | Farfel Gail M Dir | Buy | Durect Corp | DRRX | $0.39 | $8,584 | +50.00% |
| May 12, 2020 | May 13, 2020 | Farfel Gail M EVP Chief Development Officer | Sell | Zogenix, Inc. | ZGNX | $28.21 | $72,584 | -33.76% |
| Aug 22, 2019 | Aug 23, 2019 | Farfel Gail M EVP Chief Development Officer | Sell | Zogenix, Inc. | ZGNX | $52 | $179,192 | -41.33% |
| Oct 04, 2018 | Oct 09, 2018 | Farfel Gail M EVP Chief Development Officer | Sell | Zogenix, Inc. | ZGNX | $43.23 | $300,928 | -49.35% |
| Sep 04, 2018 | Sep 05, 2018 | Farfel Gail M EVP Chief Development Officer | Sell | Zogenix, Inc. | ZGNX | $47.58 | $333,042 | -49.49% |
| Aug 08, 2018 | Aug 10, 2018 | Farfel Gail M EVP Chief Development Officer | Sell | Zogenix, Inc. | ZGNX | $52.62 | $368,313 | -49.49% |
| Jun 12, 2018 | Jun 14, 2018 | Farfel Gail M EVP Chief Development Officer | Sell | Zogenix, Inc. | ZGNX | $45 | $230,310 | -41.74% |
| Apr 21, 2015 | Apr 23, 2015 | Farfel Gail M Chief Clinical Dev Reg Offic | Sell | Marinus Pharmaceuticals Inc | MRNS | $9.48 | $284,511 | -0 |